UPDATE: Credit Suisse Downgrades Cubist Pharmaceuticals On Execution Risk To Global Expansion Of Hospital Franchise
November 20, 2014 at 08:11 AM EST
In a report published Thursday, Credit Suisse analyst Jason Kantor downgraded the rating on Cubist Pharmaceuticals Inc (NASDAQ: CBST) ...